![Deborah Baron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deborah Baron
Directeur/Membre du Conseil chez
CEREVEL THERAPEUTICS HOLDINGS, INC.
Profil
Ms. Deborah Baron is a Director & Vice President at Seagen, Inc., an Independent Director at Cerevel Therapeutics Holdings, Inc., a Chief Executive Officer at Amplyx Pharmaceuticals, Inc. and a President at Encysive Pharmaceuticals, Inc. She is on the Board of Directors at Metsera, Inc., Seagen, Inc., Cerevel Therapeutics Holdings, Inc. and Cerevel Therapeutics, Inc. Ms. Baron was previously employed as a President & Director by Trillium Therapeutics, Inc. and a Senior VP-Worldwide Business Development by Pfizer Inc. She also served on the board at Global Blood Therapeutics, Inc. She received her undergraduate degree from Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
Postes actifs de Deborah Baron
| Sociétés | Poste | Début |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Directeur/Membre du Conseil | 20/01/2021 |
| SEAGEN INC. | Directeur/Membre du Conseil | 14/12/2023 |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Directeur Général | - |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Directeur/Membre du Conseil | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | President | - |
Anciens postes connus de Deborah Baron
| Sociétés | Poste | Fin |
|---|---|---|
| TRILLIUM THERAPEUTICS | President | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Formation de Deborah Baron
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
